Synthetic biologist, programmer of cells, and lover of all things visual. Wakes up in the morning to learn some of natures secrets and do a spot of fly fishing.
Applications are open for Astera Residencies, now through January 7, 2027! Up to $2M in funding, based out of our Emeryville hub. This round, we’re sharing a few specific project requests. Read more and apply here: astera.org/residency/
Reshare with folks who should see this!
I’m looking for a special hire to help shape a core pillar of Manifold Bio: enabling powerful AI to create medicines.
At Manifold, we've built a learning loop between AI drug design and biological reality. We can physically test millions of protein designs, including directly in living systems, and pair that capability with cutting-edge AI protein design (see our mBER-2 pre-print that set records in scale, epitope coverage, and novel formats). In short, we have the greatest throughput and lowest latency of data generation of molecules tested in relevant systems in the world. This is the engine behind our $2B collaboration with Roche with more coming soon.
I’m calling the role Product Manager for AI Platform & Partnerships. The role reports directly to me. It spans strategy, engineering, business development, and alliance management with three core remits:
- Shape our AI roadmap: prioritize what we build, design evals to steer system evolution, and help turn ideas into tools our scientists use.
- Evolve our AI partnerships: identify opportunities, connect them to our capabilities, and turn them into joint projects and compelling demos.
- Make our AI capabilities tangible: build interactive demos that show scientists and partners what’s possible, and help shape what we build next.
I’m looking for someone with good instincts for how to seize this moment. You need to be able to work across scientists, engineers, and external partners. You should have opinions on how to best leverage AI systems, as well as what’s possible given the physical reality interface we’ve built. You should have a clear view on how the ecosystem is evolving, and a track-record of building apps or workflows using modern AI tools. A traditional PM background isn’t required.
I’m looking for someone with deep curiosity, high slope, and a track record of moving matter and making things happen. Please reach out or find an intro to me directly.
We funded 10 grad students to publish their hidden science. The work fell into three groups: results with no home in a paper, datasets too valuable to sit on a server, and tools that help other scientists work.
See the results ➡ asterainstitute.substack.com…
We're launching a Creative Fellowship for an artist or scientific illustrator at @AsimovPress. This is a paid, 20hr/wk, three-month program (with negotiable, but competitive, pay.) You'd help revamp our website and make all the art for our upcoming Issue, plus work on your own projects.
If you are interested, please send three samples of prior work to my email, niko[at]asimov[dot]com, with a few sentences about who you are and why you are interested. We are especially looking for artists or illustrators who have an understanding of biology, yet maintain a unique style. (Art below by Ella Watkins-Dulaney.)
The degree to which it is over for Nvidia cannot be overstated. You _cannot_ have bean counters in charge of a technical organization like that. This is their Paul Otellini moment. The whole thing will be marked down to a 4x multiple.
My teaching this year clashes with @BiochemSoc SynBioUK 2026 😥 Fear not though, The Biocompute Lab is in strong attendance with posters on (P037) biometrology📏, (P064) genome editing tools🛠️ and (P012) optogenetics💡 and a talk on tunable gene expression at 14:45 today 🎸!
The new goal at @AsimovPress is to publish exceptional, technical, long-form reporting on biotechnology; the types of stories that no outlet is doing.
We are allocating most of our budget toward paying great journalists and also artists who can bring these stories to life. The long-term aim is to win a Pulitzer for biotechnology reporting. This also means we'll be publishing less often, because these stories can take 3-6 months to produce.
We'll publish non-reported essays on occasion, but only if they have a thesis that is super compelling and, ideally, could *only* be written by a particular person. (e.g. We have a piece coming up about lead testing, written by a person who is developing those kits.)
Please email editors@asimov.com if you have a big story that you are itching to write; especially if other outlets aren't willing to give you the time or funds to do it properly.
A big thanks to @BBSRC, @EPSRC, @royalsociety and others for funding and support. This is the second of numerous strains (SHARK was our first doi.org/10.1021/acssynbio.5c…) we are looking to release soon to help accelerate all sorts of synthetic and engineering biology!
🚨New work on estabishing design rules for compact CRISPR-based genetic circuitry using Cas12m🧬
Work led by the hugely creative @JoShiv04. My fav bit is a 2-input, 2-output circuit able to regulate two metabolic pathways using only 730 bp of genetic code!
biorxiv.org/content/10.64898…
After recently moving to the University of Oxford, I am currently recruiting PhD students in the broad areas of web systems, social computing and Internet measurements. If you know of anybody, please let them know to reach out (deadline 2nd December)!
After the labs IPO, there will be many multi-millionaires looking for their next gig.
May I suggest a millionaire - scientist buddy system...
We already have nice labs and plenty of cool, world-changing projects.
All we need is a match-making service. ;)
I mean yeah I hope we do get stunning advances, but I also know how unforgivingly hard biology is, especially to the uninitiated. All these mainstream Ai ppl suddenly caring about Ai is cute and all but they better not waste patient's time. This is actually serious work for once.
Today is an emotional day for me. Together with Prof. John McCutcheon lab @ASU we have visualized by cryoEM what looks like a very funky ribosome from an insect endosymbiont.
We believe there are important evolutionary implications.
Here the pre-print:
biorxiv.org/content/10.64898…
What the resolution of a neuron model does to the computation? 👇
neurovium.science/posts/pblo…
We show how higher-order neural interactions can appear pairwise under coarse-graining, concealing the underlying computation. Dendritic nonlinearities and their spatial organization matter for computational capacity, challenging whether point-neuron networks and scalar weights provide a sufficient abstraction for NeuroAI.
ps. Thanks to Tyler @tylerxhobbs, my writing now fashions the infamous "Fidenza"!